GlassScriptPhysician profile
Carissa A Coorough
NPI 1588949333
$2,904.83
in general payments reported to CMS, 2019-2025
27 companies · $18.94 in 2025
The $18.94 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,085 · 2022: $1,404 · 2023: $397 · 2025: $18.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.41 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $405.36 | 2021-2023 | Xtandi |
| Pfizer INC. | $307.51 | 2021-2023 | |
| Endo Pharmaceuticals INC. | $278.19 | 2021-2022 | |
| Abbvie INC. | $222.77 | 2021-2023 | |
| Allergan, INC. | $185.98 | 2021-2022 | |
| Rochester Medical Corporation | $159.58 | 2021-2022 | |
| Janssen Biotech, INC. | $147.12 | 2021-2023 | Erleada |
| Integra Lifesciences Corporation | $135.08 | 2022 | |
| Procept Biorobotics Corporation | $122.42 | 2022 | |
| Sumitomo Pharma America, INC. | $102.69 | 2023-2025 | Orgovyx, Gemtesa |
| Amgen INC. | $99.31 | 2021-2023 | Prolia |
| Dendreon Pharmaceuticals LLC | $82.87 | 2021-2022 | |
| Angiodynamics, INC. | $77.10 | 2021-2022 | |
| Axonics, INC. | $69.00 | 2021 | |
| Urogen Pharma, INC. | $67.99 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $62.45 | 2021-2022 | |
| Blue Earth Diagnostics | $56.35 | 2021-2022 | |
| 180 Medical, INC. | $52.96 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $47.95 | 2021 | |
| Urovant Sciences INC | $41.05 | 2022 | |
| Teleflex LLC | $37.28 | 2021-2022 | |
| Myovant Sciences INC. | $29.32 | 2021 | |
| Coloplast Corp | $26.44 | 2022 | |
| Travere Therapeutics, INC. | $25.45 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.03 | 2021 | |
| Olympus America INC. | $22.36 | 2022 | |
| Progenics Pharmaceuticals, INC. | $16.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carissa Coorough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.